about
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the ...
Read More
1.71
0.09
(5.56%)
2.2M
XNAS Volume
XNAS 04 Mar, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Invivyd Inc is on 06 Mar 2026 for the purpose of Invivyd Inc Fourth Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Invivyd Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..